スマートドラッグ＆ピル市場：対象領域、タイプ、エンドユーザー、用途別-2023-2030年の世界予測

スマートドラッグ＆ピルの世界市場は大きく成長し、2023年には82億8,036万米ドル、CAGR 23.99%と予測され、2030年には377億1,107万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のスマートドラッグ＆ピル市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.スマートドラッグ＆ピルの世界市場規模および予測は？

2.予測期間中、世界のスマートドラッグ＆ピル市場を形成するCOVID-19の阻害要因と影響は？

3.スマートドラッグ＆ピルの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.スマートドラッグ＆ピルの世界市場における競争戦略は？

5.スマートドラッグ＆ピルの世界市場における技術動向と規制の枠組みは？

6.スマートドラッグ＆ピルの世界市場における主要ベンダーの市場シェアは？

7.スマートドラッグ＆ピルの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者人口の増加と慢性疾患の有病率の上昇
    • より良い診断のために低侵襲手術を求める患者の増加
    • 認知機能を強化するスマートドラッグ＆ピルの人気が高まる
  • 抑制要因
    • スマートドラッグ＆ピルに関連する高コスト
  • 機会
    • スマートドラッグ＆ピルにおける継続的な技術の進歩と革新
    • スマートドラッグ＆ピルの開発における研究開発投資の増加
  • 課題
    • スマートドラッグ＆ピルに関連する副作用
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 スマートドラッグ＆ピル市場対象エリア別

• 食道
• 大腸
• 小腸
• お腹

第7章 スマートドラッグ＆ピル市場：タイプ別

• 市販の向知性薬
  • カフェイン
  • クレアチン
  • L-テアニン
  • オメガ3脂肪酸
  • ラセタム
• 処方された向知性薬

第8章 スマートドラッグ＆ピル市場：エンドユーザー別

• 診断センター
• 病院
• 調査機関

第9章 スマートドラッグ＆ピル市場：用途別

• カプセル内視鏡検査
• ドラッグデリバリー
• 患者のモニタリング

第10章 南北アメリカのスマートドラッグ＆ピル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のスマートドラッグ＆ピル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのスマートドラッグ＆ピル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別
  • 契約、コラボレーション、パートナーシップ
  • 新製品発売と機能強化
  • 受賞・表彰・拡大

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. SMART DRUGS & PILLS MARKET RESEARCH PROCESS
• FIGURE 2. SMART DRUGS & PILLS MARKET SIZE, 2022 VS 2030
• FIGURE 3. SMART DRUGS & PILLS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2022 VS 2030 (%)
• FIGURE 5. SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 6. SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 7. SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 8. SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. SMART DRUGS & PILLS MARKET DYNAMICS
• FIGURE 10. SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. SMART DRUGS & PILLS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. SMART DRUGS & PILLS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. SMART DRUGS & PILLS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. SMART DRUGS & PILLS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 5. SMART DRUGS & PILLS MARKET SIZE, BY ESOPHAGUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. SMART DRUGS & PILLS MARKET SIZE, BY LARGE INTESTINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. SMART DRUGS & PILLS MARKET SIZE, BY SMALL INTESTINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. SMART DRUGS & PILLS MARKET SIZE, BY STOMACH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 10. SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 11. SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. SMART DRUGS & PILLS MARKET SIZE, BY CAFFEINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. SMART DRUGS & PILLS MARKET SIZE, BY CREATINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. SMART DRUGS & PILLS MARKET SIZE, BY L-THEANINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. SMART DRUGS & PILLS MARKET SIZE, BY OMEGA-3 FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. SMART DRUGS & PILLS MARKET SIZE, BY RACETAMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. SMART DRUGS & PILLS MARKET SIZE, BY PRESCRIPTION NOOTROPICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. SMART DRUGS & PILLS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. SMART DRUGS & PILLS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. SMART DRUGS & PILLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. SMART DRUGS & PILLS MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. SMART DRUGS & PILLS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. SMART DRUGS & PILLS MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. CANADA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 43. CANADA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 45. CANADA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. CANADA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. CHINA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 70. CHINA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 72. CHINA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. CHINA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. INDIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 75. INDIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 77. INDIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. INDIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. ITALY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 161. ITALY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 163. ITALY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. ITALY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. POLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 181. POLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 183. POLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 184. POLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. QATAR SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 186. QATAR SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 188. QATAR SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 189. QATAR SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. SMART DRUGS & PILLS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 236. SMART DRUGS & PILLS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 237. SMART DRUGS & PILLS MARKET LICENSE & PRICING

The Global Smart Drugs & Pills Market is forecasted to grow significantly, with a projected USD 8,280.36 million in 2023 at a CAGR of 23.99% and expected to reach a staggering USD 37,711.07 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Smart Drugs & Pills Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Smart Drugs & Pills Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Target Area, market is studied across Esophagus, Large Intestine, Small Intestine, and Stomach. The Small Intestine commanded largest market share of 39.67% in 2022, followed by Large Intestine.

Based on Type, market is studied across Over-the-Counter Nootropics and Prescription Nootropics. The Over-the-Counter Nootropics is further studied across Caffeine, Creatine, L-theanine, Omega-3 fatty acids, and Racetams. The Prescription Nootropics commanded largest market share of 59.45% in 2022, followed by Over-the-Counter Nootropics.

Based on End User, market is studied across Diagnostic Centers, Hospitals, and Research Institutes. The Hospitals commanded largest market share of 51.84% in 2022, followed by Diagnostic Centers.

Based on Application, market is studied across Capsule Endoscopy, Drug Delivery, and Patient Monitoring. The Capsule Endoscopy commanded largest market share of 36.45% in 2022, followed by Drug Delivery.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 39.45% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Smart Drugs & Pills Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Smart Drugs & Pills Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Smart Drugs & Pills Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Smart Drugs & Pills Market?

4. What is the competitive strategic window for opportunities in the Global Smart Drugs & Pills Market?

5. What are the technology trends and regulatory frameworks in the Global Smart Drugs & Pills Market?

6. What is the market share of the leading vendors in the Global Smart Drugs & Pills Market?

7. What modes and strategic moves are considered suitable for entering the Global Smart Drugs & Pills Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Smart Drugs & Pills Market, by Target Area, 2022 vs 2030
• 4.3. Smart Drugs & Pills Market, by Type, 2022 vs 2030
• 4.4. Smart Drugs & Pills Market, by End User, 2022 vs 2030
• 4.5. Smart Drugs & Pills Market, by Application, 2022 vs 2030
• 4.6. Smart Drugs & Pills Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing geriatric population coupled with rising prevalence of chronic disorders
    • 5.1.1.2. Increased patient preference for minimally invasive surgeries for better diagnosis
    • 5.1.1.3. Rising popularity of smart drugs & pills to enhance cognitive functions
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with smart drugs & pills
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing technological advancements and innovations in smart drugs & pills
    • 5.1.3.2. Increasing research and development investment in developing smart drugs & pills
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse reactions associated with smart drugs & pills
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Smart Drugs & Pills Market, by Target Area

• 6.1. Introduction
• 6.2. Esophagus
• 6.3. Large Intestine
• 6.4. Small Intestine
• 6.5. Stomach

7. Smart Drugs & Pills Market, by Type

• 7.1. Introduction
• 7.2. Over-the-Counter Nootropics
  • 7.2.1. Caffeine
  • 7.2.2. Creatine
  • 7.2.3. L-theanine
  • 7.2.4. Omega-3 fatty acids
  • 7.2.5. Racetams
• 7.3. Prescription Nootropics

8. Smart Drugs & Pills Market, by End User

• 8.1. Introduction
• 8.2. Diagnostic Centers
• 8.3. Hospitals
• 8.4. Research Institutes

9. Smart Drugs & Pills Market, by Application

• 9.1. Introduction
• 9.2. Capsule Endoscopy
• 9.3. Drug Delivery
• 9.4. Patient Monitoring

10. Americas Smart Drugs & Pills Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Smart Drugs & Pills Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Smart Drugs & Pills Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player
  • 13.3.1. Agreement, Collaboration, & Partnership
    • 13.3.1.1. BD, BIOCORP Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs
    • 13.3.1.2. AdhereTech Announces Partnership with AARDEX Group to Boost Medication Adherence with Smart Pill Bottle, Software and Data Analytics
    • 13.3.1.3. Smart pill startup etectRx strikes partnership with Pear Therapeutics
  • 13.3.2. New Product Launch & Enhancement
    • 13.3.2.1. Hamilton Beach Brands, Inc. and HealthBeacon plc Announce the US Launch of the Smart Sharps Bin™ Injection Care Management System
  • 13.3.3. Award, Recognition, & Expansion
    • 13.3.3.1. AARDEX Group adds etectRx to their MEMS Adherence Hardware ecosystem
    • 13.3.3.2. Olympus Moves into New Headquarters in Hamburg - Olympus EMEA
    • 13.3.3.3. "CapsoVision Inc. Announces FDA Enforcement Discretion for At-Home Capsule Endoscopy Administration of CapsoCam Plus during COVID-19"

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing